| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cell, Tumor, and Stem Cell Biology |
Expression in Human Lung Carcinoma Cells through Activation of PI3K/mTOR and Suppression of AP-2
1 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Emory University School of Medicine; 2 Atlanta Veterans Affairs Medical Center, Atlanta, Georgia and 3 Tianjin Medical University General Hospital, Tianjin Lung Cancer Institute, Tianjin Medical University, Tianjin, People's Republic of China
Requests for reprints: ShouWei Han, Division of Pulmonary, Allergy and Critical Care Medicine, Emory University School of Medicine, Whitehead Bioresearch Building, 615 Michael Street, Suite 205-M, Atlanta, GA 30322. Phone: 404-712-2661; Fax: 404-712-2151; E-mail: shan2{at}emory.edu.
Key Words: PPARβ/
Nicotine
7 nAChR AP-2
PI3K/mTOR human lung carcinoma cells
We previously showed that nicotine stimulates non–small cell lung carcinoma (NSCLC) cell proliferation through nicotinic acetylcholine receptor (nAChR)–mediated signals. Activation of peroxisome proliferator–activated receptor β/
(PPARβ/
) has also been shown to induce NSCLC cell growth. Here, we explore the potential link between nicotine and PPARβ/
and report that nicotine increases the expression of PPARβ/
protein; this effect was blocked by an
7 nAChR antagonist (
-bungarotoxin), by
7 nAChR short interfering RNA, and by inhibitors of phosphatidylinositol 3-kinase (PI3K; wortmannin and LY294002) and mammalian target of rapamycin (mTOR; rapamycin). In contrast, this effect was enhanced by PUN282987, an
7 nAChR agonist. Silencing of PPARβ/
attenuated the stimulatory effect of nicotine on cell growth, which was overcome by transfection of an exogenous PPARβ/
expression vector. Of note, nicotine induced complex formation between
7 nAChR and PPARβ/
protein and increased PPARβ/
gene promoter activity through inhibition of AP-2
as shown by reduced AP-2
binding using electrophoretic gel mobility shift and chromatin immunoprecipitation assays. In addition, silencing of Sp1 attenuated the effect of nicotine on PPARβ/
. Collectively, our results show that nicotine increases PPARβ/
gene expression through
7 nAChR–mediated activation of PI3K/mTOR signals that inhibit AP-2
protein expression and DNA binding activity to the PPARβ/
gene promoter. Sp1 seems to modulate this process. This study unveils a novel mechanism by which nicotine promotes human lung carcinoma cell growth. [Cancer Res 2009;69(16):6445–53]
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |